Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Apply
Intismeran & Pembrolizumab
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step